Dermata Therapeutics, Inc. (DRMA) vs GRI Bio, Inc. (GRI)
Dermata Therapeutics, Inc. and GRI Bio, Inc. are both Biotechnology companies. Dermata Therapeutics, Inc. and GRI Bio, Inc. are of similar size ($4.7M and $4.6M). Dermata Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; GRI Bio, Inc. trades at 0.0×. Across the 8 metrics below, GRI Bio, Inc. leads on 7 and Dermata Therapeutics, Inc. on 1.
Valuation
Profitability
| Metric | DRMA | GRI | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (183.89%) | (142.02%) | (57.72%) |
| Return on assets | (139.93%) | (113.27%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack